Delivery Order SPE2DB22D3501-SPE2DB26FTH27
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,706.84 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Journavx 50 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 7, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for supply of Journavx 50 mg tablets (30-count packaging) valued at $3,048.36. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,536.24 to AmerisourceBergen Drug Corp for the supply of Journavx 50 mg tablets (30-count units) under a firm fixed price contract. The award was issued on October 28, 2025, with an ultimate completion date of October 29, 2025. This non-competitive delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $5,094.95 to AmerisourceBergen Drug Corp for the supply of Journavx 50 mg tablets (30-count units) under firm fixed pricing terms. The contract was competitively awarded without set-aside designation and is scheduled for completion by November 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,136.12 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Journavx 50 mg tablets (30-count packaging). The contract is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Journavx 50 mg tablets in unit dose packaging (100 count). This is a firm fixed-price delivery order with a ceiling value of $3,305.43, with an ultimate completion date of July 1, 2025. The award utilizes no set-aside designation and represents a competitively awarded contract. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- This delivery order, valued at $5,998.20, was awarded to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Journavx 50 mg tablets (30-count units) to support federal medical procurement needs. The contract represents a non-competitive, firm fixed-price delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and running through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Journavx 50 mg tablets (30-count units) valued at $1,561.55. This non-set-aside, competitively awarded contract employs firm fixed pricing and carries an ultimate completion date of August 27, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,248.02 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Journavx 50 mg on December 17, 2025, with completion scheduled for December 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $12,518.12 to AmerisourceBergen Drug Corp for Journavx 50 mg tablets (30-count packaging) on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTH27Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Journavx 50 mg tablets in unit dose packaging (100 count) under a firm fixed price contract valued at $1,239.88. This delivery order, issued on October 29, 2025, represents a child contract under the larger Indefinite Delivery Contract vehicle and requires completion by October 30, 2025. The award was made through open competition with no set-aside designation, demonstrating the contractor's capability to compete for federal pharmaceutical procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor providing extensive medical commodities including brand-name and generic medications, vaccines, and specialized supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's track record of competitively awarded delivery orders with firm fixed pricing demonstrates its established capability to fulfill federal medical supply requirements efficiently across varying order sizes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/29/25 |